Panellists included Marion Gruber from IAVI, Marco Cavaleri from the European Medicines Agency, Hanna Nohynek from the National Institute for Health and Welfare, and Thomas Waite, the UK’s Deputy Chief Medical Officer. Through rich discussion, the panel underscored the importance of transparency, innovation, and public engagement in fostering vaccine confidence and uptake.

Misinformation and Trust in Vaccination

The conversation opened with Marco Cavaleri, who was reflecting on lessons from COVID-19. “To increase vaccine uptake, we need to rebuild trust,” he stated, adding that misinformation spread rapidly during the pandemic, leaving an “unfortunate, traumatic impact on public perception.” Cavaleri emphasised the role of regulators and public health authorities in maintaining “transparency about scientific data” and advocated engaging directly with citizens through modern communication channels, particularly social media, to counter misinformation.

Echoing this, Thomas Waite observed that while misinformation could be corrected through transparent education, disinformation posed a unique challenge due to its intentionally deceptive nature. “Engaging with disinformation on its terms is counterproductive,” he said, urging a clear communication approach firmly grounded in accurate, science-based information.

Transparency and Data Quality

Transparency emerged as a central pillar, with panellists stressing that open data and easy access to vaccination information play a vital role in public confidence. Hanna Nohynek spoke of Finland’s experience during COVID-19, where adverse events were reported in real time. This allowed the public to “see transparency in action,” building a stronger foundation of trust. Waite highlighted a similar approach in the UK, noting that the UK Health Security Agency’s data dashboard became a heavily used public resource, promoting transparency and providing real-time flu, RSV, and COVID-19 vaccination statistics.

Innovation and Access: Meeting New Vaccine Demands

The global vaccine pipeline is evolving rapidly, with innovations designed to address threats like respiratory diseases, antimicrobial resistance, and climate-related health impacts. Gruber remarked, “We are seeing new infectious diseases entering the northern hemisphere due to climate change, adding urgency to our need for innovative vaccines.” The conversation also spotlighted AMR (antimicrobial resistance), with Gruber discussing the advanced stages of tuberculosis vaccines. “AMR vaccines could be transformative in curbing resistance,” she added.

This innovation surge, however, brings challenges of its own. Waite noted that in the UK, “The immunisation schedule has become significantly more complex.” With the increase in adult vaccinations, including RSV, flu, shingles, and COVID-19, the programme now requires substantial public outreach to explain why vaccination remains crucial at each life stage. Gruber and Nohynek stressed that effective public engagement and education are essential to ensure uptake keeps pace with scientific advancements.

Bridging Health Inequities: Expanding Vaccine Access

Discussing global disparities, Nohynek raised the importance of equitable vaccine access, particularly for low- and middle-income countries. As she explained, the WHO’s Strategic Advisory Group of Experts (SAGE) has prioritised maternal vaccination for RSV in these regions. However, she pointed out gaps in clinical trials across continents, noting, “The absence of data from Asia, especially given high prematurity rates, underscores the need for global representation in trials.”

Gruber cited Argentina’s success with maternal RSV vaccinations as a promising case study. Argentina’s approach — a blend of government support, accessible vaccination points, and educational outreach — yielded 57% coverage in the first season. “Political will and cross-sector collaboration were key to this success,” she said, adding that lessons from Argentina could be instrumental as RSV vaccines roll out across Africa.

Economic Challenges and Prioritisation

Sibilia Quilici closed the panel by addressing the economic dimension of vaccine rollout. She argued for an economic perspective on immunisation, explaining that “vaccination is not just a health intervention but a key driver of societal and economic growth.” Nohynek highlighted the challenges her institution in Finland faces due to budget cuts, which she described as “counterproductive,” noting that restrictions on funding can hamper efforts to evaluate and introduce new vaccines effectively.

Cavaleri reinforced the need for a streamlined approach, remarking, “We need to integrate the vaccine approval process with recommendation systems to reduce the lag time. Six years from authorisation to patient arms is simply too long.”

The Path Forward: Building Resilient Immunisation Systems

The panel concluded with a unified call for increased transparency, streamlined regulatory frameworks, and sustained investment in vaccination programmes. Waite summarised the vision: “Advances in technology should make it easier for citizens to get vaccinated while service providers adapt to meet the needs of modern lifestyles.” Gruber echoed his sentiment, noting that “infections affect us all,” underscoring the importance of making vaccines accessible across diverse populations.

The panel’s insights ultimately emphasised that immunisation strategies must adapt to sustain progress, integrating public trust, technological advancements, and economic considerations. The panellists agreed that by addressing the challenges head-on, we can ensure vaccines continue to protect and empower communities globally.

The post Vaccines and Public Trust: Insights from the World Vaccine Congress Panel appeared first on Medika Life.

In late March of 2021, I wrote an article that highlighted the problems with Vanden Bossche’s theories (there are numerous) about the runaway evolution of the coronavirus if we continue with widespread vaccination. My article debunked numerous points, for instance, an immunology faux-pas he made that would make a first-year immunology student cringe in shame(he shows a dendritic cell activating an NK cell via antigen presentation) and more. You can read said article here.

This article won’t deal with his erroneous claims, we’ve done that already, but rather seek to examine how a literal nobody in the world of science has managed to propel himself to stardom (albeit notorious) in the space of a few weeks on the back of a clearly flawed paper, intentionally withheld from the peer review process for obvious reasons. Vanden Bossche isn’t out to save the world, he’s out to fleece it. Academia doesn’t pay enough.

Vanden Bossche, the marketing monster

In a self-marketing feat that would have left the likes of Apple and Samsung spinning their wheels in his dust, Geert Vanden Bossche has managed to create an iconic brand literally overnight. He portrays the image of a gentle, yet friendly and always reasonable scatterbrained professor. His hair is always a little unkept, a tip of the hat to his rebellious, but carefully controlled nature and his meticulously managed public persona just yells “trust me, I’m a doctor”.

And people apparently do, buying into both his image and his version of science. By the millions. Americans love him and well they should, given their established proclivity for drama, conspiracy, and anti-establishment propaganda. Canada follows hotly on their heels. Vanden Bossche has human nature on his side and is well aware of it. Everything he does, the language he uses, and the way he presents both himself and his theories, suggest he is all too well aware.

If he’d published his paper, created a furor, and then disappeared back into the academic obscurity from whence he came, we may even have credited him with possibly believing in the work he had published, flawed though it is. BUT HE HAS’NT. and that speaks volumes. It raises serious questions about the man, his motivation, and his plans for book deals, speaking appearances, and perhaps, dare he dream it, a movie offer. I can see the title now, “The Virologist that broke American Healthcare”.

Remember, just in case you’re tempted to confuse Vanden Bossche with a world-class microbiologist/virologist, he is actually board certified in Veterinary Virology, Microbiology, and Animal Hygiene, hasn’t published a research paper since 1995, and appears to have forgotten the basic activation mechanisms for an NK cell. But he’s not letting these minor obstacles stand in his way.

geertvandenbossche.org

Lo and behold, what should pop out of the digital ether this March but none other than Geert Vanden Bossche. His domain, geertvandenbossche.com was registered on the 14th of March 2021. Suddenly, and very coincidentally, his sudden interest to develop a website coincided with the release of his controversial “paper”. What follows is nothing short of spectacular and his epically flawed “scientific” dissection of mass vaccination pales in comparison.

From Zero to Anti-Hero in the blink of an eye. Vanden Bossche has managed to propel his previously non-existent website from total obscurity, 0 out 30 million websites to an Alexa ranking globally of 454,315. Even more impressive is the time scale. In less than two months, he now boasts being the 129,013 most read website in the US and in Canada, that figure shoots up to 32,015. Apparently, the only people who are bigger suckers than the Americans for a good Covid conspiracy are the Canadians.

To put the achievement below into proper context, he has skipped right past 29 646 000 other websites to achieve his current ranking, such is the volume of traffic he currently enjoys, traffic that mostly originates from Northern America.

Want to know where his traffic specifically comes from? Available statistics show Google sending him 31% of his traffic and Twitter accounts for 14.3%. Where do his visitors primarily go after spending an average of 1 minute 27 seconds on the site? Youtube, of course, 21.2% of his visitors head straight for his videos. The rest of his traffic, which equates to millions of views daily, isn’t available, isn’t analyzable, that how recent his success has been. Most platforms need at least three months of data to generate figures.

We have a pretty good idea where the other traffic is coming from though, having run a few backlink checks on his domain. Almost every single anti-vaxx website, alternate health website, covid conspiracy website, and even radical, Republican funded qanon styled sites have adopted Vanden Bossche, propelling him overnight to international digital stardom and enabling (which is their actual goal) the dissemination of his divisive articles and videos to a large audience. They believe they’re using Vanden Bossche to further their own agendas.

I suspect exactly the opposite is true. I think, and I’m not alone in this assumption, that Vanden Bossche has an ulterior motive and its financial. As we’ve already stated, he is intelligent and driven, but not by an altruistic desire to save his fellow man from the impending vaccine catastrophe he has prophesized.

Rather, it is to sell the world an alternative vaccine, designed and developed by none other than Vanden Bossche himself.

If you think this is a ridiculous proposition, we suggest your read up on the disgraced Andrew Wakefield, the king of the vaccine con and arguably the founder of the anti-vaxx movement. Ironic that both mens’ attempts to enrich themselves have led to a slavelike following of individuals apparently devoid of independent thought. In fact, Wakefield may very well have provided a blueprint for Vanden Bossche’s scam, the two appear similar.

The Fool-Proof Con

Vanden Bossche has created the ultimate medical con, one that is sufficiently complex to prevent his victims (the general public) from understanding it and they are therefore dependant on accepting his individual and professional credentials which on the surface appear beyond reproach. Vanden Bossche maintains an air of absolute conviction and professional dependability throughout, selling himself and by association, his ideas.

It would have been possible for him to explain his concept in far simpler terms, but it’s noticeable that these simpler phrases are retained for the shock statements, the warnings, and the “dire consequences”. The paper he created was never intended for professional dissemination and would have been ripped to pieces by his colleagues. It was designed entirely for you, dear reader. for the general public, to flummox and confuse, and judging by the interest he has generated, it’s been a spectacular success.

When it comes to this kind of work, never trust the man, trust the science. And science has proven him to be an incontrovertible fake.

Time is fleeting

And Vanden Bossche has a limited supply of it. In another six -12 months, the glaring flaws in his arguments are going to become apparent as the world does not succumb to his predicted supervirus. Also, his new conspiracy fans are a fickle mob, driven by whatever is trending on social media. In two months’ time, he’s going to be old news and it may very well be this aspect that has prompted America to do almost nothing to counteract his wild claims.

The statistics shown above indicate just how mistaken the American approach to Vanden Bossch has been. Since early April and probably well into June, he will continue to spread disinformation and distrust in the vaccines at an unprecedented rate, encouraging millions to reconsider getting vaccinated and contributing to the American failure to reach herd level immunization. Of course, Vanden Bossche can’t be credited with single-handedly contributing to America’s vaccine hesitancy.

There has been a continuous and sustained attack on vaccines almost since the idea for rapid vaccine development was first floated in early 2020. What we do know is that Vanden Bossche offer s a unique opportunity to study this model of medical quackery that is driven by greed and personal enrichment. His website and strategy show just how vulnerable international medical strategies can be to a concerted and well-supported propaganda attack.

America is about to discover just how much money they are going to have to fork out to try and undo the impact of one, Geert Vanden Bossche. Money that could have spent on healthcare, saving lives. Ensuring a mother from a disadvantaged community received enough pre-delivery care to save her and her child. Somehow, I doubt Vanden Bossche has trouble falling asleep at night. He just doesn’t seem the type.

Whoever is tasking with holding these quacks and con-artists accountable in a post-pandemic society (people will demand it), may not view him as kindly. He has blood on his hands and his words and advice continue to claim lives.

The post How Geert Vanden Bossche is Destroying American Herd Immunity appeared first on Medika Life.